Angiotensin II does not acutely regulate conduction velocity in rat atrial tissue

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 71, Issue 6, 2011, Pages 492-499

  Olsen, Kristine B ^a   Braunstein, Thomas H ^a   Sørensen, Charlotte M ^a   Axelsen, Lene N ^a   Holstein Rathlou, Niels Henrik ^a   Nielsen, Morten S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Arrhythmia; atrial fibrillation; conduction velocity; contractile force; myocardial infarction; renin angiotensin system

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; CYCLOPHILIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART ATRIUM; HEART ATRIUM CONDUCTION; HEART INFARCTION; HEART LEFT VENTRICLE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOTENSIN II; ANIMALS; ANTERIOR WALL MYOCARDIAL INFARCTION; DIASTOLE; HEART ATRIA; HEART VENTRICLES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; TRANSCRIPTION, GENETIC; VASOCONSTRICTOR AGENTS;

RATTUS;

EID: 80052949394     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2011.589009     Document Type: Article

References (29)

1. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fi brillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999;100:376-80. (Pubitemid 29362407)
2. Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A. Enalapril decreases the incidence of atrial fi brillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003;107:2926-31. (Pubitemid 36736634)
3. Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB. Angiotensin II receptor blockade reduces new-onset atrial fi brillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005;45:712-9. (Pubitemid 40282586)
4. Schneider MP, Hua TA, Bö h m M, Wachtell K, Kjeldsen SE, Schmieder RE. Prevention of atrial fi brillation by reninangiotensin system inhibition: a meta-analysis. J Am Coll Cardiol 2010;55:2299-307.
5. Burstein B, Nattel S. Atrial fi brosis: mechanisms and clinical relevance in atrial fi brillation. J Am Coll Cardiol 2008;51:802-9. (Pubitemid 351260071)
6. De Mello WC, Altieri P. The role of the renin-angiotensin system in the control of cell communication in the heart: effects of enalapril and angiotensin II. J Cardiovasc Pharmacol 1992;20:643-51.
7. De Mello WC. Renin-angiotensin system and cell communication in the failing heart. Hypertension 1996;27:1267-72. (Pubitemid 26165629)
8. Hofgaard JP, Banach K, Mollerup S, Jorgensen HK, Olesen SP, Holstein-Rathlou NH, Nielsen MS. Phosphatidylinositol- bisphosphate regulates intercellular coupling in cardiac myocytes. Pfl ugers Arch 2008;457:303-13.
9. Hussain WAJI, Patel PM, Chowdhury RA, Cabo CAND, Ciaccio EJ, Lab MJ, Duffy HS, Wit AL, Peters NS. The renin-angiotensin system mediates the effects of stretch on conduction velocity, connexin43 expression, and redistribution in intact ventricle. J Cardiovasc Electrophysiol 2010; 21:1276-83.
10. Hadrup N, Petersen JS, Praetorius J, Meier E, Graebe M, Brond L, Staahltoft D, Nielsen S, Christensen S, Kapusta DR, Jonassen TE. Opioid receptor-like 1 stimulation in the collecting duct induces aquaresis through vasopressin-independent aquaporin-2 downregulation. Am J Physiol Renal Physiol 2004;287:F160-8. (Pubitemid 38780595)
11. Haugan K, Olsen KB, Hartvig L, Petersen JS, Holstein-Rathlou NH, Hennan JK, Nielsen MS. The antiarrhythmic peptide analog ZP123 prevents atrial conduction slowing during metabolic stress. J Cardiovasc Electrophysiol 2005; 16:537-45. (Pubitemid 40632487)
12. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8. (Pubitemid 34164012)
13. Morley GE, Vaidya D, Samie FH, Lo C, Delmar M, Jalife J. Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J Cardiovasc Electrophysiol 1999;10:1361-75. (Pubitemid 29468576)
14. Eloff BC, Lerner DL, Yamada KA, Schuessler RB, Saffitz JE, Rosenbaum DS. High resolution optical mapping reveals conduction slowing in connexin43 defi cient mice. Cardiovasc Res 2001;51:681-90. (Pubitemid 32800710)
15. van Rijen HV, Eckardt D, Degen J, Theis M, Ott T, Willecke K, Jongsma HJ, Opthof T, de Bakker JM. Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation 2004;109: 1048-55. (Pubitemid 38282860)
16. Danik SB, Liu F, Zhang J, Suk HJ, Morley GE, Fishman GI, Gutstein DE. Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res 2004;95: 1035-41. (Pubitemid 39532334)
17. Chen SA, Chang MS, Chiang BN, Cheng KK, Lin CI. Electromechanical effects of angiotensin in human atrial tissues. J Mol Cell Cardiol 1991;23:483-93.
18. Feolde E, Vigne P, Frelin C. Angiotensin II receptor subtypes and biological responses in the rat heart. J Mol Cell Cardiol 1993;25:1359-67. (Pubitemid 24003842)
19. Holubarsch C, Hasenfuss G, Schmidt-Schweda S, Knorr A, Pieske B, Ruf T, Fasol R, Just H. Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. An in vitro study under physiological experimental conditions. Circulation 1993;88:1228-37. (Pubitemid 23264043)
20. Bauer P, Regitz-Zagrosek V, Hofmeister J, Lokies J, Rolfs A, Hildebrandt AG, Hetzer R, Fleck E. Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure: assessment by a novel quantitative PCR-ELISA technique. J Mol Med 1996;74:447-54. (Pubitemid 26261898)
21. Lenz O, Schmid B, Kilter H, La RK, Flesch M, Kuhn- Regnier F, Sudkamp M, Bohm M. Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium. Eur J Pharmacol 1995;294:17-27. (Pubitemid 26016812)
22. Mollmann H, Schmidt-Schweda S, Nef H, Mollmann S, Burstin JV, Klose S, Elsasser A, Holubarsch CJ. Contractile effects of angiotensin and endothelin in failing and nonfailing human hearts. Int J Cardiol 2007;114:34-40. (Pubitemid 44791469)
23. Baker KM, Singer HA. Identifi cation and characterization of guinea pig angiotensin II ventricular and atrial receptors: coupling to inositol phosphate production. Circ Res 1988;62:896-904.
24. Lefroy DC, Crake T, Del MF, Vescovo G, Dalla LL, Harding S, Poole-Wilson PA. Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts. Am J Physiol 1996;270:H2060-9.
25. Leite-Moreira AF, Castro-Chaves P, Pimentel-Nunes P, Lima-Carneiro A, Guerra MS, Soares JB, Ferreira-Martins J. Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na- /H- exchanger-mediated effect. Br J Pharmacol 2006;147:690-7.
26. LemariéCA, Schiffrin EL. The angiotensin II type 2 receptor in cardiovascular disease. J Renin-Angiotensin-Aldosterone Syst 2010;11:19-31.
27. Korte T, Fuchs M, Guener Z, Bonin J, de SM, Niehaus M, Tebbenjohanns J, Drexler H. In-vivo electrophysiological study in mice with chronic anterior myocardial infarction. J Interv Card Electrophysiol 2002;6:121-32. (Pubitemid 34594833)
28. Rucker-Martin C, Milliez P, Tan S, Decrouy X, Recouvreur M, Vranckx R, Delcayre C, Renaud JF, Dunia I, Segretain D, Hatem SN. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res 2006;72:69-79. (Pubitemid 44310634)
29. Rosiak M, Ruta J, Bolinska H. Usefulness of prolonged P-wave duration on signal averaged ECG in predicting atrial fi brillation in acute myocardial infarction patients. Med Sci Monit 2003;9:MT85-8. (Pubitemid 37139593)